Tourmaline Bio, Inc.
TRML
$23.31
$0.251.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.14% | 13.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.98% | 1.65% | |||
| Operating Income | 0.98% | -1.65% | |||
| Income Before Tax | -0.53% | -3.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.53% | -3.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.53% | -3.31% | |||
| EBIT | 0.98% | -1.65% | |||
| EBITDA | 0.98% | -1.64% | |||
| EPS Basic | -0.28% | -3.72% | |||
| Normalized Basic EPS | -0.29% | 22.90% | |||
| EPS Diluted | -0.28% | -3.72% | |||
| Normalized Diluted EPS | -0.29% | 22.90% | |||
| Average Basic Shares Outstanding | 0.25% | -0.40% | |||
| Average Diluted Shares Outstanding | 0.25% | -0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||